FHIR IG analyticsBy Version
By Authority
By Realm
Start Prev Rows 81800 - 82000 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) | Usage # |
|---|---|---|---|---|---|---|---|---|---|---|---|
| hl7.fhir.us.cardio.ig | R4 | ValueSet-AorticProceduresVS.json | ValueSet para procedimiento sobre la Aorta. | active | 2023-01 | us | hl7 | internal | 1 | ||
| hl7.fhir.us.cardio.ig | R4 | ValueSet-OtherCardiacProcedureDetailsVS.json | ValueSet para otros procedimientos cardiacos | active | 2023-01 | us | hl7 | internal | 1 | ||
| hl7.fhir.us.cardio.ig | R4 | ValueSet-OtherNonCardiacProcedureDetailsVS.json | ValueSet para otros procedimientos no cardiacos | active | 2023-01 | us | hl7 | internal | 1 | ||
| hl7.fhir.us.cardio.ig | R4 | ValueSet-PractitionerRoleCardioVS.json | ValueSet para otros procedimientos no cardiacos | active | 2023-01 | us | hl7 | internal | 1 | ||
| hl7.fhir.us.cardio.ig | R4 | ValueSet-AortaSegmentsVS.json | ValueSet para segmentos de la Aorta. | active | 2023-01 | us | hl7 | internal | 1 | ||
| hl7.fhir.us.cardio.ig | R4 | ValueSet-ExtracorporealCirculationVS.json | Valores para la circulación extracorpórea. | active | 2023-01 | us | hl7 | internal | 1 | ||
| hl7.fhir.us.cardio.ig | R4 | ValueSet-NativeValvePathologyVS.json | Valores para la patología de válvula nativa. | active | 2023-01 | us | hl7 | internal | 1 | ||
| hl7.fhir.us.cardio.ig | R4 | ValueSet-EndocarditisInfecciosaVS.json | Valores aceptados para endocarditis infecciosa. | active | 2023-01 | us | hl7 | sct | 1 | ||
| br.go.ses.core | R4 | ValueSet-uso-nome-cidadao.json | Tipo de uso do nome do cidadão | active | 2025-11 | fhir | 1 | ||||
| br.ufpb.cardioremoto | R4 | ValueSet-remote-monitoring-status-vs.json | Conjunto de valores de Status de Monitoramento Remoto | active | 2026-07 | uv | internal | ||||
| br.go.ses.core | R4 | ValueSet-relacao-contato.json | RelacaoContato | active | 2025-11 | tho | 1 | ||||
| hl7.fhir.uv.ips | R4 | ValueSet-results-radiology-observations-uv-ips.json | Results Radiology Observation - IPS | trial-use | 3 | pc | 2026-06 | uv | hl7 | loinc | 11 |
| hl7.cda.uv.ips | R4 | ValueSet-2.16.840.1.113883.11.22.40--20240802104807.json | IPS Results Radiology Observation | draft | 2024-08 | uv | hl7 | loinc | 1 | ||
| hl7.fhir.uv.ips | R4 | ValueSet-results-laboratory-pathology-observations-uv-ips.json | Results Laboratory/Pathology Observation - IPS | trial-use | 3 | pc | 2026-06 | uv | hl7 | loinc | 5 |
| ans.fhir.fr.eclaire | R4 | ValueSet-eclaire-study-party-role-vs.json | Value Set Eclaire pour les différents rôles des parties impliquées dans l'essai | draft | 2024-02 | fr | national | internal | |||
| ans.fhir.fr.eclaire | R4 | ValueSet-eclaire-study-party-organization-type-vs.json | Value Set Eclaire pour les types de parties | draft | 2024-02 | fr | national | internal | |||
| ans.fhir.fr.eclaire | R4 | ValueSet-eclaire-study-status-vs.json | Value Set Statut Eclaire de l'essai | draft | 2024-02 | fr | national | internal | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.3.1489.json | ACE Inhibitor or ARB or ARNI Ingredient | active | 2023-02 | us | hl7 | vsac | |||
| hl7.fhir.cz.lab-order | R4 | ValueSet-cz-typeClinicalEvent-vs.json | Valueset of types Clinical event (CZ) | trial-use | 2 | 2024-01 | cz | hl7 | internal | 1 | |
| hl7.fhir.us.davinci-pct | R4 | ValueSet-PCTAdjudicationCategoryVS.json | PCT GFE Item Adjudication Value Set | trial-use | 2 | fm | 2026-03 | us | hl7 | fhir tho | 1 |
| hl7.fhir.be.terminology | R4 | ValueSet-be-vs-populationscreening-next-invitation-type.json | Population Screening Next Invitation Type Value Set | active | 1 | 2024-06 | be | hl7 | 1 | ||
| hl7.fhir.uv.cow | R4 | ValueSet-message-header-event.json | Clinical Orders Workflow - Message Header Event Codes | trial-use | 1 | oo | 2026-04 | uv | hl7 | fhir | 1 |
| br.go.ses.reds-go | R4 | ValueSet-BRProcedimentosNacionais-1.0.json | Procedimento realizado | draft | 2020-04 | br | internal | 2 | |||
| ans.fhir.fr.eclaire | R4 | ValueSet-eclaire-study-phase-source-vs.json | Value Set de la phase de l'essai tel que définie dans la base ECLAIRE | draft | 2024-02 | fr | national | internal | |||
| hl7.fhir.uv.radiation-dose-summary | R4 | ValueSet-component-radiation-dose-summary-vs.json | Radiation Dose Summary component type | trial-use | 2 | ii | 2026-05 | uv | hl7 | sct dcm | 1 |
| ans.fhir.fr.eclaire | R4 | ValueSet-eclaire-group-characteristic-kind-vs.json | Type de caractéristique Value Set | draft | 2024-02 | fr | national | internal | 1 | ||
| uz.dhp.core | R5 | ValueSet-action-participant-role-vs.json | Action Participant Role VS | draft | 2026-07 | sct | 1 | ||||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-authorisation-type.json | CH - Authorisation Type | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-authorisation-type-vs.json | CH - Authorisation Type | active | 2026-06 | ch | hl7 | internal | 1 | ||
| bloodpressure | R4 | ValueSet-us-core-modified-blood-pressure-category.json | Vital Signs Blood Pressure Category Codes | draft | 2026-06 | internal | |||||
| ch.fhir.ig.ch-orf | R4 | ValueSet-ch-orf-vs-appointmentstatus.json | Appointment Status | active | 2025-12 | ch | hl7 | fhir | 1 | ||
| ch.fhir.ig.ch-orf | R4 | ValueSet-ch-orf-vs-consentstatus.json | Consent Status | active | 2025-12 | ch | hl7 | internal sct | 1 | ||
| ch.fhir.ig.ch-orf | R4 | ValueSet-ch-orf-vs-coverageidentifiertype.json | Coverage Identifier Type | active | 2025-12 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-orf | R4 | ValueSet-ch-orf-vs-desiredaccommodation.json | Desired Accomodation | active | 2025-12 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-orf | R4 | ValueSet-ch-orf-vs-encounterclass.json | Encounter Class | active | 2025-12 | ch | hl7 | tho | 1 | ||
| ch.fhir.ig.ch-epr-fhir | R4 | ValueSet-PpqmConsentIdentifierType.json | CH PPQm Consent Identifier Type | active | 2026-06 | ch | hl7 | internal | |||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-wachstumstyp-clo.json | MII VS Biobank Wachstumpstyp CLO | active | 2025-09 | de | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-containertyp-sct.json | MII VS Biobank Containertyp SCT | active | 2025-09 | de | sct | 1 | |||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-dna-concentration-units-ucum.json | MII VS Biobank DNA Concentration Units UCUM | active | 2025-09 | de | ucum | 1 | |||
| uz.dhp.core | R5 | ValueSet-goal-achievement-vs.json | Goal Achievement VS | draft | 2026-07 | tho | 1 | ||||
| uz.dhp.core | R5 | ValueSet-goal-category-vs.json | Goal Category VS | draft | 2026-07 | tho | 1 | ||||
| uz.dhp.core | R5 | ValueSet-goal-description-vs.json | Goal Description VS | draft | 2026-07 | sct | 1 | ||||
| uz.dhp.core | R5 | ValueSet-goal-priority-vs.json | Goal Priority VS | draft | 2026-07 | tho | 1 | ||||
| uz.dhp.core | R5 | ValueSet-goal-start-event-vs.json | Goal Start Event VS | draft | 2026-07 | sct | 1 | ||||
| uz.dhp.core | R5 | ValueSet-goal-status-vs.json | Goal Status VS | draft | 2026-07 | fhir | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-karyotyp-sct.json | MII VS Biobank Karyotyp SCT | active | 2025-09 | de | sct | 1 | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.10.20.22.5.305.json | Microbiology and Antimicrobial Susceptibility Tests | active | 2024-06 | us | hl7 | loinc | |||
| ch.fhir.ig.ch-orf | R4 | ValueSet-ch-orf-vs-legalrelation.json | Legal Relation | active | 2025-12 | ch | hl7 | sct | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-epl-foph-limitationstatus.json | CH EPL - Limitation Status | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-epl-foph-listing-status.json | CH EPL - Listing Status | active | 2026-06 | ch | hl7 | internal | |||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-cellline-morphology-sct.json | MII VS Biobank Cellinie Morphology SCT | active | 2025-09 | de | sct | 1 | |||
| myhie.v4-test | R4 | ValueSet-observation-obstetric-us-my-core.json | ValueSetObservationObstetricUs (MY Core) | active | 2023-04 | loinc | 1 | ||||
| myhie.v4-test | R4 | ValueSet-observation-vital-signs-my-core.json | ValueSetObservationVitalSigns (MY Core) | active | 2022-08 | loinc | 6 | ||||
| myhie.v4-test | R4 | ValueSet-observation-vsc-bp-my-core.json | ValueSetObservationVSCBP (MY Core) | active | 2022-08 | loinc | 2 | ||||
| myhie.v4-test | R4 | ValueSet-observation-vsc-hr-my-core.json | ValueSetObservationVSCHR (MY Core) | active | 2022-08 | loinc | 1 | ||||
| myhie.v4-test | R4 | ValueSet-observation-vsc-s02-my-core.json | ValueSetObservationVSCSO2 (MY Core) | active | 2022-08 | loinc | 2 | ||||
| myhie.v4-test | R4 | ValueSet-observation-vsc-t-my-core.json | ValueSetObservationVSCT (MY Core) | active | 2022-08 | loinc | 1 | ||||
| hl7.fhir.us.directory-query | R4 | ValueSet-OrganizationAffiliationRoleVS.json | OrganizationAffiliation Roles | active | 2022-12 | us | hl7 | fhir | 1 | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet-OrganizationAffiliationRoleVS.json | OrganizationAffiliation Roles | trial-use | fm | 2026-06 | us | hl7 | fhir | 2 | |
| hl7.fhir.us.directory-attestation | R4 | ValueSet-OrganizationAffiliationRoleVS.json | OrganizationAffiliation Roles | active | 2022-12 | us | hl7 | fhir | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-other-characteristics-type.json | CH - Other Characteristics Type | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-other-characteristics-type.json | CH - Other Characteristics Type | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-epl-foph-other-characteristics-packaged-item.json | CH EPL - Other Characteristics Packaged Item | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-epr-ppqm | R4 | ValueSet-PpqmConsentIdentifierType.json | PPQm Consent Identifier Type | active | 2023-12 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-orf | R4 | ValueSet-ch-orf-vs-personalrelation.json | Personal Relation | active | 2025-12 | ch | hl7 | sct | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-epl-foph-pricetype.json | CH EPL - Price Type | active | 2026-06 | ch | hl7 | internal | |||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-cellline-proliferation.json | MII VS Biobank Proliferation Zellinie | active | 2025-09 | de | sct | 1 | |||
| hl7.fhir.us.qicore | R4 | ValueSet-qicore-present-on-admission.json | QICore Present On Admission Codes | trial-use | 4 | cqi | 2021-05 | us | hl7 | cms | |
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-epl-foph-reimbursement-status.json | CH EPL - Reimbursement Status | active | 2026-06 | ch | hl7 | internal | |||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-probenart-sct.json | MII VS Biobank Probenart SCT | active | 2025-09 | de | sct | 1 | |||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-body-structures-sct.json | MII VS Biobank BodyStructures SCT | active | 2025-09 | de | sct | 1 | |||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-laboratory-procedure-sct.json | MII VS Biobank Laboratory Procedure SCT | active | 2025-09 | de | sct | 1 | |||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-substance-additive-sct.json | MII VS Biobank Substance Additive | active | 2025-09 | de | sct | 1 | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-epl-foph-type-of-price-change.json | CH EPL - Type of Price Change | active | 2026-06 | ch | hl7 | internal | |||
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-cellline-modification-clo.json | MII VS Biobank Cellline Modification CLO | active | 2025-09 | de | 1 | ||||
| fhir.onc.us-quality-core | R4 | ValueSet-us-quality-core-present-on-admission.json | USQualityCore Present On Admission Codes | active | 2026-06 | us | hl7 | cms | 1 | ||
| ch.fhir.ig.ch-emr | R4 | ValueSet-ch-emr-clinical-document-types-vs.json | Clinical Document Types | active | 2026-05 | ch | hl7 | sct | 1 | ||
| hl7.fhir.uv.genomics-reporting | R4 | ValueSet-tbd-codes-vs.json | To Be Determined Value Set | informative | cg | 2026-01 | uv | hl7 | fhir | ||
| hl7.fhir.uv.genomics-reporting | R4 | ValueSet-condition-inheritance-mode-vs.json | Condition Inheritance Patterns | trial-use | 2 | cg | 2026-01 | uv | hl7 | gene | 2 |
| hl7.fhir.be.terminology | R4 | ValueSet-be-vs-coded-annotation-types.json | Coded Annotation Types | active | 1 | 2022-09 | be | hl7 | 1 | ||
| hl7.fhir.uv.genomics-reporting | R4 | ValueSet-coded-annotation-types-vs.json | Coded Annotation Types | trial-use | 2 | cg | 2026-01 | uv | hl7 | fhir | 1 |
| hl7.fhir.uv.genomics-reporting | R4 | ValueSet-sequence-phase-relationship-vs.json | Sequence Phase Relationships | trial-use | 2 | cg | 2026-01 | uv | hl7 | tho | 1 |
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | ValueSet-mii-vs-biobank-probenebene.json | MII VS Biobank Probenebene | active | 2025-09 | de | 1 | ||||
| hl7.fhir.uv.genomics-reporting | R4 | ValueSet-molecular-biomarker-code-vs.json | Molecular Biomarker Codes | trial-use | 2 | cg | 2026-01 | uv | hl7 | ncit loinc | 1 |
| hl7.fhir.uv.genomics-reporting | R4 | ValueSet-genetic-therapeutic-implications-vs.json | Genetic Therapeutic Implications | trial-use | 2 | cg | 2026-01 | uv | hl7 | sct loinc | 1 |
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-additional-monitoring-indicator.json | CH SMC - Additional Monitoring Indicator | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-additional-monitoring-indicator.json | CH SMC - Additional Monitoring Indicator | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-authorisation-category.json | CH SMC - Authorisation Category | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-authorisation-category.json | CH SMC - Authorisation Category | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-authorisation-status.json | CH SMC - Authorisation Status | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-authorisation-status.json | CH SMC - Authorisation Status | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-authorised-pharmaceutical-dose-form.json | CH SMC - Authorised Pharmaceutical Dose Form | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-authorised-pharmaceutical-dose-form.json | CH SMC - Authorised Pharmaceutical Dose Form | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-edqm-combination-packaging.json | EDQM - Combination Packaging | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-edqm-combination-packaging.json | EDQM - Combination Packaging | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-edqm-combined-pharmaceutical-dose-form.json | EDQM - Combined Pharmaceutical Dose Form | active | 2026-06 | ch | hl7 | 2 | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-edqm-combined-pharmaceutical-dose-form.json | EDQM - Combined Pharmaceutical Dose Form | active | 2026-06 | ch | hl7 | 2 | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-edqm-combined-term.json | EDQM - Combined Term | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-edqm-combined-term.json | EDQM - Combined Term | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ema-domain.json | EMA - Domain | active | 2026-06 | ch | hl7 | ||||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ema-domain.json | EMA - Domain | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-epl-foph-gamme.json | CH EPL - Gamme | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-ingredient-role.json | CH SMC - Ingredient Role | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-ingredient-role.json | CH SMC - Ingredient Role | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ema-intended-effect.json | EMA - Intended Effect | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ema-intended-effect.json | EMA - Intended Effect | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-attached-document-type.json | CH SMC - Attached Document Type | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-legal-status-of-supply.json | CH SMC - Legal Status of Supply | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-attached-document-type.json | CH SMC - Attached Document Type | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-legal-status-of-supply.json | CH SMC - Legal Status of Supply | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-Refdata-marketing-status.json | CH Refdata - Marketing Status | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-marketing-status.json | CH SMC - Marketing Status | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-marketing-status.json | CH SMC - Marketing Status | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-medicinal-product-name-type.json | CH - Medicinal Product Name Type | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-medicinal-product-name-type.json | CH - Medicinal Product Name Type | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-MedicinalProductCategory.json | CH SMC - MedicinalProductCategory | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-edqm-packaging.json | EDQM - Packaging | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-edqm-packaging.json | EDQM - Packaging | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-pediatric-use-indicator.json | CH SMC - Pediatric Use Indicator | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-pediatric-use-indicator.json | CH SMC - Pediatric Use Indicator | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-edqm-pharmaceutical-dose-form.json | EDQM - Pharmaceutical Dose Form | active | 2026-06 | ch | hl7 | 2 | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-edqm-pharmaceutical-dose-form.json | EDQM - Pharmaceutical Dose Form | active | 2026-06 | ch | hl7 | 3 | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-epl-foph-product-type.json | CH EPL - Product Type | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-edqm-route-of-administration.json | EDQM - Route Of Administration | active | 2026-06 | ch | hl7 | ||||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-edqm-route-of-administration.json | EDQM - Route Of Administration | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ema-shelf-life-type.json | EMA - Shelf Life Type | active | 2026-06 | ch | hl7 | ||||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ema-shelf-life-type.json | EMA - Shelf Life Type | active | 2026-06 | ch | hl7 | ||||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-special-precautions-for-storage.json | CH SMC - Special Precautions for Storage | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-special-precautions-for-storage.json | CH SMC - Special Precautions for Storage | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-substance.json | CH SMC - Substance | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-ch-SMC-substance.json | CH SMC - Substance | active | 2026-06 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-epl | R5 | ValueSet-ch-SMC-therapeuticproductcode.json | CH SMC - TherapeuticProductcode | active | 2026-06 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-epl | R5 | ValueSet-edqm-unit-of-presentation.json | EDQM - Unit of Presentation | active | 2026-06 | ch | hl7 | 1 | |||
| ch.fhir.ig.ch-idmp | R5 | ValueSet-edqm-unit-of-presentation.json | EDQM - Unit of Presentation | active | 2026-06 | ch | hl7 | 2 | |||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-mamma-menopause-status.json | MII_VS_Onko_Mamma_Menopause_Status | active | de | sct | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-prostata-postsurgical-complications.json | MII_VS_Onko_Prostata_Postsurgical_Complications | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-prostata-clavien-dindo.json | MII_VS_Onko_Prostata_Clavien_Dindo | active | de | sct | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-prostata-gleason-score.json | MII_VS_Onko_Prostata_Gleason_Score | active | de | sct | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-mamma-her2neu-status-leitlinie.json | MII VS Onkologie Mamma Her2neu Status Leitlinie | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-mamma-her2neu-status-obds.json | MII VS Onkologie Mamma Her2neu Status oBDS | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-mamma-praeoperative-markierung-modalitaet.json | MII_VS_Onko_Mamma_Praeoperative_Markierung_Modalitaet | active | de | sct | 2 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-asa-loinc.json | MII_VS_Onko_ASA_LOINC | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-melanom-ldh.json | MII_VS_Onko_Melanom_LDH | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-mamma-operation-ops.json | MII_VS_Onko_Mamma_Operation_OPS | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-mamma-operation-sct.json | MII_VS_Onko_Mamma_Operation_SCT | active | de | sct | 1 | ||||
| de.gematik.terminology | R4 | ValueSet-ti-medication-type-vs.json | TI Medication Type Value Set | active | 2025-09 | de | sct | 1 | |||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-melanom-exzision-snomedct.json | MII VS Onko Melanom Exzision SNOMED CT | active | de | sct | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-prostata-gleason-primary-secondary-tertiary.json | MII_VS_Onko_Prostata_Gleason_PrimarySecondaryTertiary | active | de | sct | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-prostata-operation-snomedct.json | MII VS Onko Prostata Operation SNOMED CT | active | de | sct | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-prostata-psa-loinc.json | MII VS Onko Prostata PSA LOINC | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-krk-stoma-status-reason.json | MII_VS_Onko_KRK_Stoma_Status_Reason | active | de | sct | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-krk-anastomoseninsuffizienz.json | MII_VS_Onko_KRK_Anastomoseninsuffizienz | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-prostata-gleason-patterns.json | MII VS Onkologie Prostata Gleason Patterns | active | de | sct | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-mamma-intraoperatives-imaging-praeparat.json | MII_VS_Onko_Mamma_Intraoperatives_Imaging_Praeparat | active | de | sct | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-asa-obds.json | MII_VS_Onko_ASA_oBDS | active | de | 2 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-studienteilnahme.json | MII VS Onkologie Studienteilnahme | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-genetische-variante-auspraegung.json | MII_VS Onkologie Genetische Variante Ausprägung | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-fernmetastasen.json | MII VS Onkologie Fernmetastasen | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-operation-intention.json | MII VS Onkologie Operation Intention | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-strahlentherapie-intention.json | MII VS Onkologie Strahlentherapie Intention | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-systemische-therapie-intention.json | MII VS Onkologie Systemische Therapie Intention | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-operation-komplikation.json | MII VS Onkologie Operation Komplikationen | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-allgemeiner-leistungszustand-ecog.json | MII VS Onkologie Allgemeiner Leistungszustand nach ECOG | active | de | 2 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-allgemeiner-leistungszustand-karnofsky.json | MII VS Onkologie Allgemeiner Leistungszustand nach Karnofsky | active | de | 2 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-beurteilung-lokaler-residualstatus.json | MII VS Onkologie Beurteilung des lokalen Residualstatus | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-gesamtbeurteilung-residualstatus.json | MII VS Onkologie Gesamtbeurteilung des Residualstatus | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-tod.json | MII VS Onkologie Tod | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-mamma-rezeptorstatus-leitlinie.json | MII_VS_Onko_Mamma_Rezeptorstatus_Leitlinie | active | de | 2 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-mamma-rezeptorstatus-obds.json | MII_VS_Onko_Mamma_Rezeptorstatus_oBDS | active | de | loinc | 2 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-operation-urgency.json | MII_VS_Onko_Operation_Urgency | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-krk-stoma-anzeichnung.json | MII_VS_Onko_KRK_Stoma_Anzeichnung | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-krk-abstand-resektionslinie-aboral.json | MII_VS_Onko_KRK_Abstand_Resektionslinie_Aboral | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-krk-tme-qualitaet.json | MII_VS_Onko_KRK_TME_Qualitaet | active | de | 1 | |||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-krk-abstand-circumferelle-resektionsrand.json | MII_VS_Onko_KRK_Abstand_Circumferelle_Resektionsrand | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet-mii-vs-onko-krk-mrt-mesorektale-faszie-status.json | MII_VS_Onko_KRK_MRT_Mesorektale_Faszie_Status | active | de | 1 | |||||
| hl7.fhir.cz.terminology | R4 | ValueSet-eHDSIReactionAllergy.json | eHDSI Reaction Allergy | active | 2025-12 | cz | hl7 | sct | 1 | ||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VSresponseFlag.json | Response Flag (2.8.2 - 1.0.0) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0121.json | hl7VS-responseFlag | active | 2019-12 | uv | hl7 | tho | |||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VStransportArranged.json | Transport Arranged (2.8.2 - 1.0.0) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0224.json | hl7VS-transportArranged | active | 2019-12 | uv | hl7 | tho | |||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VSsequencing.json | Sequencing (2.8.2 - 1.0.0) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0397.json | hl7VS-sequencing | active | 2019-12 | uv | hl7 | tho | 1 | ||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VSlivingDependency.json | Living Dependency (2.8.2 - 2.0.0) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0223.json | hl7VS-livingDependency | active | 2019-12 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v2-0393.json | hl7VS-matchAlgorithms | active | 2019-12 | uv | hl7 | tho | |||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VSprocessingType.json | Processing Type (2.8.2 - 1.0.0) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0388.json | hl7VS-processingType | active | 2019-12 | uv | hl7 | tho | |||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VSanalyteRepeatStatus.json | Analyte Repeat Status (2.8.2 - 1.0.0) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0389.json | hl7VS-analyteRepeatStatus | active | 2019-12 | uv | hl7 | tho | |||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VScommandResponse.json | Command Response (2.8.2 - 1.0.1) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0387.json | hl7VS-commandResponse | active | 2019-12 | uv | hl7 | tho | |||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VSsubstanceStatus.json | Substance Status (2.8.2 - 1.0.0) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0383.json | hl7VS-substanceStatus | active | 2019-12 | uv | hl7 | tho | |||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VSresponseModality.json | Response Modality (2.8.2 - 1.0.0) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0394.json | hl7VS-responseModality | active | 2019-12 | uv | hl7 | tho | |||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VSsubstanceType.json | Substance Type (2.8.2 - 1.0.1) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0384.json | hl7VS-substanceType | active | 2019-12 | uv | hl7 | tho | |||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VSmatchReason.json | Match Reason (2.8.2 - 1.0.0) | active | 2026-06 | hl7 | tho | ||||
| hl7.terminology | R5 | ValueSet-v2-0392.json | hl7VS-matchReason | active | 2019-12 | uv | hl7 | tho | |||
| hl7.v2.uv.terminology.v282 | R4 | ValueSet-hl7VScontinuationStyleCode.json | Continuation Style Code (2.8.2 - 1.0.0) | active | 2026-06 | hl7 | tho |
FHIR
FHIRsmith